Skip to content ↓

Sen. Whitehouse visits Alcator C-Mod Tokamak

U.S. Sen. Sheldon Whitehouse of Rhode Island (right), accompanied (right to left) by MIT alumnus Reinier Beeuwkes and PSFC Associate Director Martin Greenwald, listens to Alcator C-Mod Project Head Earl Marmar discuss the importance of fusion research at MIT.
Caption:
U.S. Sen. Sheldon Whitehouse of Rhode Island (right), accompanied (right to left) by MIT alumnus Reinier Beeuwkes and PSFC Associate Director Martin Greenwald, listens to Alcator C-Mod Project Head Earl Marmar discuss the importance of fusion research at MIT.
Credits:
Photo: Mary Pat McNally
Birds-eye view of Alcator C-Mod.
Caption:
Birds-eye view of Alcator C-Mod.
Credits:
Photo: PSFC

On Oct. 26, U.S. Senator Sheldon Whitehouse of Rhode Island visited MIT’s Plasma Science and Fusion Center for a tour of the Alcator C-Mod facility. Led by PSFC Associate Director Martin Greenwald and Alcator Project Head Earl Marmar, the senator was briefed for about 90 minutes on MIT’s research program in fusion energy. 

The senator has a keen interest in clean energy and environmental issues and is a member of the Senate budget committee. Sen. Whitehouse was accompanied by MIT alumnus Reiner Beeukwkes ’67 and former Massachusetts Congressman Chet Atkins, who facilitated the tour.

Related Links

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story